|
Armando Sardi, M.D., F.A.C.S.FIELD: Surgical Oncology POSITION/TITLE: Director, The Institute for Cancer Care at Mercy, head of Division of Surgical Oncology BACKGROUND: Dr. Sardi is a surgical oncologist with a special interest in the treatment of intra-abdominal malignancies. Dr. Sardi earned his M.D. in his native South America at the Universidad del Valle in Colombia. After graduation, he completed a one-year internship in Colombia and then moved on to a second internship at South Baltimore General Hospital. Thereafter, he enrolled in and completed residency programs at South Baltimore General and St. Agnes HealthCare. Dr. Sardi completed his training as a fellow in oncologic surgery at The Ohio State University. Dr. Sardi practiced as a surgical oncologist at the Ochsner Clinic in New Orleans, and was the founding Chief of Surgical Oncology at Health Care International in Glasgow. In 1994, he was named Chief of Surgical Oncology at St. Agnes Hospital in Baltimore and was later appointed Medical Director of the Clinical Research Center. Dr. Sardi joined Mercy Medical Center in Baltimore City in February 2006. MISCELLANEOUS: Dr. Sardi one of the select few surgical oncologists in the world who employs leading edge procedures such as HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to treat advanced stages of abdominal cancers. HIPEC is an aggressive surgical treatment reserved for patients with peritoneal surface malignancies. The procedure, which can take up to 15 hours to perform, combines the extensive removal of cancerous tumors with a highly concentrated dose of heated chemotherapy applied directly to the peritoneal cavity.
|
